These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 34555075)
1. Advanced radiotherapy technique in hepatocellular carcinoma with portal vein thrombosis: Feasibility and clinical outcomes. Khorprasert C; Thonglert K; Alisanant P; Amornwichet N PLoS One; 2021; 16(9):e0257556. PubMed ID: 34555075 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy. Matsuo Y; Yoshida K; Nishimura H; Ejima Y; Miyawaki D; Uezono H; Ishihara T; Mayahara H; Fukumoto T; Ku Y; Yamaguchi M; Sugimoto K; Sasaki R J Radiat Res; 2016 Sep; 57(5):512-523. PubMed ID: 27053259 [TBL] [Abstract][Full Text] [Related]
3. Clinical outcome and toxicity of radiotherapy for inferior vena cava tumor thrombus in HCC patients: A retrospective study. Lee SJ; Jang HS; Choi YK Medicine (Baltimore); 2021 Jun; 100(25):e26390. PubMed ID: 34160420 [TBL] [Abstract][Full Text] [Related]
4. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis. Xi M; Zhang L; Zhao L; Li QQ; Guo SP; Feng ZZ; Deng XW; Huang XY; Liu MZ PLoS One; 2013; 8(5):e63864. PubMed ID: 23737955 [TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis. Shui Y; Yu W; Ren X; Guo Y; Xu J; Ma T; Zhang B; Wu J; Li Q; Hu Q; Shen L; Bai X; Liang T; Wei Q Radiat Oncol; 2018 Sep; 13(1):188. PubMed ID: 30253783 [TBL] [Abstract][Full Text] [Related]
7. Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram. Li X; Ye Z; Lin S; Pang H BMC Cancer; 2021 Jun; 21(1):701. PubMed ID: 34126955 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic Evaluation of Radiotherapy with Contrast-Enhanced Ultrasound in Non-Resectable Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis. Li H; Liu J; Chen M; Li H; Long L Med Sci Monit; 2018 Nov; 24():8183-8189. PubMed ID: 30426970 [TBL] [Abstract][Full Text] [Related]
9. Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy? Srivastava A; Parambath HK; Ramdulari AV; Saxena H; Kumar R; Pandey S; Shalimar ; Gupta S; Jee B Int J Radiat Biol; 2022; 98(10):1495-1509. PubMed ID: 35311612 [TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy versus intensity-modulated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis. Li LQ; Zhou Y; Huang Y; Liang P; Liang SX; Su TS Hepatol Int; 2021 Jun; 15(3):630-641. PubMed ID: 33818714 [TBL] [Abstract][Full Text] [Related]
11. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area. Im JH; Yoon SM; Park HC; Kim JH; Yu JI; Kim TH; Kim JW; Nam TK; Kim K; Jang HS; Kim JH; Kim MS; Yoon WS; Jung I; Seong J Liver Int; 2017 Jan; 37(1):90-100. PubMed ID: 27317941 [TBL] [Abstract][Full Text] [Related]
12. Comparison of three-dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus. Su F; Chen KH; Liang ZG; Wu CH; Li L; Qu S; Chen L; Zhu XD; Zhong JH; Li LQ; Xiang BD Cancer Med; 2018 Sep; 7(9):4387-4395. PubMed ID: 30062844 [TBL] [Abstract][Full Text] [Related]
13. MRI-guided radiotherapy for PVTT in HCC patients: evaluation of the efficacy and safety. Lee SJ; Kim M; Kwak YK; Kang HJ J Cancer Res Clin Oncol; 2022 Sep; 148(9):2405-2414. PubMed ID: 34490584 [TBL] [Abstract][Full Text] [Related]
14. Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification. Okazaki E; Yamamoto A; Nishida N; Hamuro M; Ogino R; Hosono M; Shimatani Y; Tsutsumi S; Hamamoto S; Sohgawa E; Jogo A; Miki Y Br J Radiol; 2016 Jul; 89(1063):20150945. PubMed ID: 27164029 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma]. Wu DH; Chen LH Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921 [TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy versus lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity matching score analysis. Ji X; Zhang A; Duan X; Wang Q Radiat Oncol; 2024 Oct; 19(1):143. PubMed ID: 39394613 [TBL] [Abstract][Full Text] [Related]
17. Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Kim JY; Yoo EJ; Jang JW; Kwon JH; Kim KJ; Kay CS Radiat Oncol; 2013 Jan; 8():15. PubMed ID: 23324259 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of high-dose three-dimensional conformal radiotherapy in hepatocellular carcinoma with portal vein thrombosis. Rim CH; Yang DS; Park YJ; Yoon WS; Lee JA; Kim CY Jpn J Clin Oncol; 2012 Aug; 42(8):721-9. PubMed ID: 22689916 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease. Choi HS; Kang KM; Jeong BK; Jeong H; Lee YH; Ha IB; Song JH Asia Pac J Clin Oncol; 2021 Jun; 17(3):209-215. PubMed ID: 32757461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]